1. From the Human Neurotransmitters (E.L., C.I.S., T.D., J.N., M.M., N.E., R.C., N.S., M.E., G.L.), Neurovascular Hypertension and Kidney Disease (M.S.), and Neuropharmacology (K.C., G.H.) Laboratories, Baker IDI Heart and Diabetes Institute, Heart Centre, Alfred Hospital (C.W.), and Faculty of Medicine, Nursing and Health Sciences (M.E., M.S., G.L.), and Departments of Physiology (E.L.) and Pharmacology (G.H.), Monash University, Melbourne, Victoria, Australia.